ATAI Life Sciences N.V.
ATAI
Market Cap$286.26M
Close$
$0.17
89.9% downside
Current Fair Value
89.9% downsideOvervalued by 89.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $286.26 Million |
|---|---|
| Enterprise Value | $196.47 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.21 |
| Beta | 0.0 |
| Outstanding Shares | 167,406,070 |
| Avg 30 Day Volume | 942,146 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.47 |
|---|---|
| PEG | 43.7 |
| Price to Sales | - |
| Price to Book Ratio | 1.71 |
| Enterprise Value to Revenue | 709.27 |
| Enterprise Value to EBIT | -1.63 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
ESG Score
No data
About ATAI Life Sciences N.V.
35 employees